Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

Peptide-based vaccine fails to protect mice against SARS-CoV-2 despite T cell response

Peptide-based vaccine fails to protect mice against SARS-CoV-2 despite T cell response

Molecular insights on the possible connection of SARS-CoV-2 and nicotinic acetylcholine receptors

Molecular insights on the possible connection of SARS-CoV-2 and nicotinic acetylcholine receptors

Study finds lower prevalence of post-acute SARS-CoV-2 symptomology in vaccinated individuals

Study finds lower prevalence of post-acute SARS-CoV-2 symptomology in vaccinated individuals

Distributed lag models to estimate incident rates using concentrations of SARS-CoV-2 RNA from wastewater solids

Distributed lag models to estimate incident rates using concentrations of SARS-CoV-2 RNA from wastewater solids

Health events amongst pregnant females after COVID-19 vaccination

Health events amongst pregnant females after COVID-19 vaccination

Triple antibody cocktail is a promising candidate for immunotherapy against SARS-CoV-2 variants of concern

Triple antibody cocktail is a promising candidate for immunotherapy against SARS-CoV-2 variants of concern

The need for a holistic and unbiased approach to develop a more universal vaccine for coronaviruses

The need for a holistic and unbiased approach to develop a more universal vaccine for coronaviruses

Study finds Omicron sublineage BA.2 is less pathogenic in rodent models than prior SARS-CoV-2 variants

Study finds Omicron sublineage BA.2 is less pathogenic in rodent models than prior SARS-CoV-2 variants

The demise of single-payer in California trips up efforts in other states

The demise of single-payer in California trips up efforts in other states

From Alabama to Utah, efforts to vaccinate Medicaid enrollees against covid run into obstacles

From Alabama to Utah, efforts to vaccinate Medicaid enrollees against covid run into obstacles

Studying coagulopathy in COVID-19

Studying coagulopathy in COVID-19

Noncovalent protease inhibitors against SARS-CoV-2 and other coronaviruses

Noncovalent protease inhibitors against SARS-CoV-2 and other coronaviruses

Vaccination reduces risk of long-COVID

Vaccination reduces risk of long-COVID

SARS-CoV-2 monitoring could be improved with use of bacterial metatranscriptomes in wastewater

SARS-CoV-2 monitoring could be improved with use of bacterial metatranscriptomes in wastewater

No seroprevalence observed against SARS-CoV-2 in wild ruminants in Germany

No seroprevalence observed against SARS-CoV-2 in wild ruminants in Germany

Study determines effectiveness of COVID-19 vaccination against Omicron variant in high-risk indoor settings

Study determines effectiveness of COVID-19 vaccination against Omicron variant in high-risk indoor settings

Will Omicron BA.2 become the next dominant variant?

Will Omicron BA.2 become the next dominant variant?

Emergence of SARS-CoV-2 Omicron likely due to immune selective pressure

Emergence of SARS-CoV-2 Omicron likely due to immune selective pressure

Altered microbiomes in SARS-CoV-2 infection pose threat of antibiotic resistance

Altered microbiomes in SARS-CoV-2 infection pose threat of antibiotic resistance

The epidemiology of COVID-19 in Africa

The epidemiology of COVID-19 in Africa

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.